Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure

American Journal of Cardiology

Volumn 94, Issue 12, 2004, Pages 1501-1505

  Jorde, Ulrich P ^a   Vittorio, Timothy J ^b   Dimayuga, Clarito A ^b   Homma, Shunichi ^b   Rizkala, Adel ^b   Le Jemtel, Thierry H ^b   Katz, Stuart D ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; TRANDOLAPRIL; ANGIOTENSIN II; INDOLE DERIVATIVE;

ADULT; ANAEROBIC THRESHOLD; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; ENDOTHELIUM CELL; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE INHIBITION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CIRCULATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; OXYGEN CONSUMPTION; PLASMA RENIN ACTIVITY; PRESSOR RESPONSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; BLOOD; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; DRUG EFFECT; EXERCISE TOLERANCE; MIDDLE AGED; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ENALAPRIL; ENDOTHELIUM, VASCULAR; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INDOLES; MALE; MIDDLE AGED; RENIN-ANGIOTENSIN SYSTEM;

EID: 13944279191     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.08.027     Document Type: Article

References (18)

1. C. Bardelay, E. Mach, M. Worcel, P. Hunt Angiotensin-converting enzyme in rat brain and extraneural tissues visualized by quantitative autoradiography using 3H-trandolaprilate J Cardiovasc Pharmacol 14 1989 511 518
2. H. Conen, H.R. Brunner Pharmacologic profile of trandolapril, a new angiotensin-converting enzyme inhibitor Am Heart J 125 1993 1525 1531
3. L. Vaur, C. Dutrey-Dupagne, J. Boussac, N. Genes, M. Bouvier d'Yvoire, F. Elkik, P.A. Meredith Differential effects of a missed dose of trandolapril and enalapril on blood pressure control in hypertensive patients J Cardiovasc Pharmacol 26 1995 127 131
4. A. Luchner, T.L. Stevens, D.D. Borgeson, M.M. Redfield, J.E. Bailey, S.M. Sandberg, D.M. Heublein, J.C. Burnett Jr Angiotensin II in the evolution of experimental heart failure Hypertension 28 1996 472 477
5. U.P. Jorde, P.V. Ennezat, J. Lisker, V. Suryadevara, J. Infeld, S. Cukon, A. Hammer, E.H. Sonnenblick, T.H. Le Jemtel Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure Circulation 101 2000 844 846
6. M.C. Corretti, G.D. Plotnick, R.A. Vogel Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound Am J Physiol 268 1995 H1397 H1404
7. S.D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J Am Coll Cardiol 36 2000 845 851
8. G.W. Neuberg, S.H. Friedman, M.B. Weiss, M.V. Herman Cardiopulmonary exercise testing The clinical value of gas exchange data Arch Intern Med 148 1988 2221 2226
9. D.W. Cushman, H.S. Cheung Concentrations of angiotensin-converting enzyme in tissues of the rat Biochim Biophys Acta 250 1971 261 265
10. M.P. Schuijt, R. de Vries, P.R. Saxena, M.A. Schalekamp, A.H. Danser Vasoconstriction is determined by interstitial rather than circulating angiotensin II Br J Pharmacol 135 2002 275 283
11. J.M. Cole, N. Khokhlova, R.L. Sutliff, J.W. Adams, K.M. Disher, H. Zhao, M.R. Capecchi, P. Corvol, K.E. Bernstein Mice lacking endothelial ACE: normal blood pressure with elevated angiotensin II Hypertension 41 2003 313 321
12. D. Lyons, J. Webster, N. Benjamin Effect of enalapril and quinapril on forearm vascular ACE in man Eur J Clin Pharmacol 51 1997 373 378
13. C.A. Farquharson, A.D. Struthers Gradual reactivation over time of vascular tissue angiotensin I to angiotensin II conversion during chronic lisinopril therapy in chronic heart failure J Am Coll Cardiol 39 2002 767 775
14. B. Hornig, N. Arakawa, D. Haussmann, H. Drexler Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure Circulation 98 1998 2842 2848
15. Anderson TJ, Elstein E, Haber H. Comparative study of ACE-inhibition, angiotensin II antagonism and calcium channel blockade on flow-mediated vasodilation in patients with coronary artery study (BANFF study). J Am Coll Cardiol 2000;35:60-66.
16. B. Hornig, U. Landmesser, C. Kohler, D. Ahlersmann, S. Spiekermann, A. Christoph, H. Tatge, H. Drexler Comparative effect of ACE inhibition and angiotensin II type 1 receptor antagonism on bioavailability of nitric oxide in patients with coronary artery disease: role of superoxide dismutase Circulation 103 2001 799 805
17. C. Giannattasio, F. Achilli, A. Grappiolo, M. Failla, E. Meles, G. Gentile, I. Calchera, A. Capra, J. Baglivo, A. Vincenzi, L. Sala, G. Mancia Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment Hypertension 38 2001 1451 1455
18. S.G. Drakos, C.M. Papamichael, G.P. Alexopoulos, M.I. Anastasiou-Nana, J.V. Stathopoulos, J.N. Nanas Effects of high doses versus standard doses of enalapril on endothelial cell function in patients with chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy Am J Cardiol 91 2003 885 888